ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,821Medicare Part D Prescriptions Filled, Including Refills

Rank: 86 out of 393

$389K Total Retail Price of All Prescriptions

Rank: 108 out of 393

214 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 214 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 5,503 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
SIMVASTATIN 505 367 1 1
LEVOTHYROXINE SODIUM 417 342 2 3
LISINOPRIL 414 302 3 2
OMEPRAZOLE 402 323 4 6
FUROSEMIDE 345 280 5 8
METOPROLOL TARTRATE 282 210 6 9
POTASSIUM CHLORIDE 270 199 7 20
AMLODIPINE BESYLATE 259 214 8 4
METFORMIN HCL 224 147 9 7
ACTOS 206 156 10 78
GABAPENTIN 205 128 11 15
RANITIDINE HCL 192 106 12 29
PLAVIX 167 116 13 51
HYDROCHLOROTHIAZIDE 154 107 14 10
CARVEDILOL 149 107 15 21
TAMSULOSIN HCL 110 102 16 25
ISOSORBIDE MONONITRATE ER 109 84 17 67
ADVAIR DISKUS 101 68 18 53
LEVEMIR 99 59 19 236
SPIRIVA 97 67 20 41
GLIMEPIRIDE 97 63 20 39
GLIPIZIDE XL 96 78 22 237
LOSARTAN POTASSIUM 94 65 23 12
CRESTOR 93 59 24 52
FLUNISOLIDE 86 77 25 242
CITALOPRAM HBR 80 50 26 23
ALLOPURINOL 71 50 27 26
PROVENTIL HFA 65 38 28 267
PROAIR HFA 65 43 28 68
SPIRONOLACTONE 64 44 30 82
TRAVATAN Z 61 46 31 273
AMITRIPTYLINE HCL 57 48 R 32 72
FENOFIBRATE 57 35 32 43
JANUVIA 54 36 34 87
CLOPIDOGREL 54 47 34 33
HYDROCODONE-ACETAMINOPHEN 50 42 S3 36 5
CYCLOBENZAPRINE HCL 50 37 R 36 109
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 23, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.